Symbols

OABI

OmniAb·NASDAQ

--(--)

OABI Profile

Omniab, Inc.

A biotech company that develops and commercializes novel antibody therapeutics

Industry

Biological Technology

Established Date

12/14/2015

Listing Date

09/30/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.omniab.com

Security Type

Common stock

Office address

5980 Horton Street, Suite 600, Emeryville, CA 94608

Business

Introduction

OmniAb, Inc., was incorporated on December 14, 2015 under the laws of the State of Delaware. The company licenses its proprietary discovery research technology to pharmaceutical and biotechnology partners to support the development of next-generation antibody-based therapies. Its platform utilizes engineered transgenic animals and computer simulation tools to generate and screen a diverse antibody library for drug development.